Table 1 Patient clinical and disease characteristics
Patient characteristic | n = 90 |
|---|---|
Age | |
 Mean | 60.6 |
 Range | 30–87 |
Sex | |
 Female | 30 (33%) |
 Male | 60 (67%) |
Stage | |
 IIIC | 5 (6%) |
 M1a | 7 (8%) |
 M1b | 17 (19%) |
 M1c | 61 (67%) |
Mutation | |
 BRAFV600E | 16 (18%) |
 BRAFV600K | 2 (2%) |
 BRAF other | 5 (6%) |
 RAS | 9 (10%) |
 Other | 1 (1%) |
 No mutation | 54 (60%) |
 Not reported | 3 (3%) |
Lactate dehydrogenase (n = 78) | |
  < 1xULN | 26 (33%) |
  > 1xULN | 52 (67%) |
Previous lines of therapy | |
 0 | 52 (58%) |
 1 | 30 (33%) |
 2 | 8 (9%) |